The sequence and structure of the 3' arm of the first stem-loop of the human immunodeficiency virus type 3 trans-activation responsive region mediate Tat-2 transactivation

被引:5
作者
Browning, C
Hilfinger, JM
Rainier, S
Lin, V
Hedderwick, S
Smith, M
Markovitz, DM
机构
[1] UNIV MICHIGAN, MED CTR, DEPT INTERNAL MED, DIV INFECT DIS, ANN ARBOR, MI 48109 USA
[2] UNIV MICHIGAN, MED CTR, DEPT MICROBIOL & IMMUNOL, ANN ARBOR, MI 48109 USA
关键词
D O I
10.1128/JVI.71.10.8048-8055.1997
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus type 2 (HIV-2) cases AIDS, but generally after a much longer asymptomatic period than that which follows infection with HIV-1. At the molecular level, HIV-2 is much more closely related to the simian immunodeficiency viruses than to HIV-1 and our precious studies have demonstrated that HIV-2 and HIV-1 enhancer stimulation is mediated by different sets of cellular proteins following T-cell activation. Similar to HIV-1, HIV-2 encodes a transactivating protein, Tat, which appears to be necessary for viral replication and stimulates viral transcriptional initiation and/or elongation. While Tat-1 binds to the RNA of the trans-activation responsive (TAR) region of HIV-1 and HIV-2, cellular factors that bind to the RNA transcript are also necessary for Tat to function in vivo. Since almost all previous investigations of cellular cofactors for Tat had focused on HIV-1, we undertook studies aimed at understanding the interaction between the TAR RNA region of the HIV-2 promoter (TAR-2) and cellular proteins. By using extension inhibition analysis (toeprinting) and RNA electrophoretic mobility shift assays, we demonstrated binding of a nuclear factor(s) in T cells to the base of the promoter-proximal stem-loop structure. Mutational analysis of this region revealed that both the sequence of the 3' arm and the stem structure itself are important for activation of the promoter by Tat-2. In contrast, the structure is necessary for activation of TAR-2 by Tat-1 but the sequence is less important. These results suggest that a cellular factor interacts with the 3' arm of the proximal stem-loop structure of TAR-2 and mediates Tat-2-induced increases in the level of HIV-2 transcripts.
引用
收藏
页码:8048 / 8055
页数:8
相关论文
共 56 条
  • [1] TRANS-ACTIVATOR GENE OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-III (HTLV-III)
    ARYA, SK
    GUO, C
    JOSEPHS, SF
    WONGSTAAL, F
    [J]. SCIENCE, 1985, 229 (4708) : 69 - 73
  • [2] IDENTIFICATION OF A NOVEL HIV-1 TAR RNA BULGE BINDING-PROTEIN
    BAKER, B
    MUCKENTHALER, M
    VIVES, E
    BLANCHARD, A
    BRADDOCK, M
    NACKEN, W
    KINGSMAN, AJ
    KINGSMAN, SM
    [J]. NUCLEIC ACIDS RESEARCH, 1994, 22 (16) : 3365 - 3372
  • [3] EFFICIENT TRANSACTIVATION BY THE HIV-2 TAT PROTEIN REQUIRES A DUPLICATED TAR RNA STRUCTURE
    BERKHOUT, B
    GATIGNOL, A
    SILVER, J
    JEANG, KT
    [J]. NUCLEIC ACIDS RESEARCH, 1990, 18 (07) : 1839 - 1846
  • [4] BORDONARO M, 1994, BIOTECHNIQUES, V16, P428
  • [5] DIRECT INTERACTIONS BETWEEN AUTOANTIGEN LA AND HUMAN-IMMUNODEFICIENCY-VIRUS LEADER RNA
    CHANG, YN
    KENAN, DJ
    KEENE, JD
    GATIGNOL, A
    JEANG, KT
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (11) : 7008 - 7020
  • [6] FUNCTIONAL IMPORTANCE OF SEQUENCE IN THE STEM-LOOP OF A TRANSCRIPTION TERMINATOR
    CHENG, SWC
    LYNCH, EC
    LEASON, KR
    COURT, DL
    SHAPIRO, BA
    FRIEDMAN, DI
    [J]. SCIENCE, 1991, 254 (5035) : 1205 - 1207
  • [7] THE PERI-KAPPA-B SITE MEDIATES HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 ENHANCER ACTIVATION IN MONOCYTES BUT NOT IN T-CELLS
    CLARK, NM
    HANNIBAL, MC
    MARKOVITZ, DM
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (08) : 4854 - 4862
  • [8] THE TRANSACTIVATOR GENE OF THE HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-III IS REQUIRED FOR REPLICATION
    DAYTON, AI
    SODROSKI, JG
    ROSEN, CA
    GOH, WC
    HASELTINE, WA
    [J]. CELL, 1986, 44 (06) : 941 - 947
  • [9] FUNCTIONAL-ANALYSIS OF THE TAT TRANS-ACTIVATOR OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-2
    FENRICK, R
    MALIM, MH
    HAUBER, J
    LE, SY
    MAIZEL, J
    CULLEN, BR
    [J]. JOURNAL OF VIROLOGY, 1989, 63 (12) : 5006 - 5012
  • [10] FU G, 1987, P NATL ACAD SCI USA, V94, P1811